Cite
HARVARD Citation
Li, Y. et al. (2020). Single‐Dose Pharmacokinetics, Safety, and Tolerability of Avadomide (CC‐122) in Subjects With Mild, Moderate, or Severe Renal Impairment. Clinical pharmacology in drug development. 9 (7), pp. 785-796. [Online].